Skip to main content

Adrenal Cortical Extract Taken Off Drug Market

HRD-81-61 Published: Apr 20, 1981. Publicly Released: May 21, 1981.
Jump To:
Skip to Highlights


Adrenal cortical extract (ACE) products were once recommended in the treatment of Addison's disease and for several other indications including hypoglycemia. In January 1978, the Food and Drug Administration (FDA) advised drug firms marketing ACE products that the drug represented a substantial risk of undertreatment because of its low potency and the resulting potential hazard to patients.

Full Report

Office of Public Affairs


DiseasesDrugsFood and drug lawPharmaceutical industryPhysiciansProduct evaluationProduct recallsRegulatory agenciesTherapyPrescription drugs